Mindset Pharma Inc.

OTCPK:MSST.F Stock Report

Market Cap: US$54.0m

Mindset Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

James Lanthier

Chief executive officer

CA$783.8k

Total compensation

CEO salary percentage28.7%
CEO tenureno data
CEO ownership2.7%
Management average tenureno data
Board average tenure3.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has James Lanthier's remuneration changed compared to Mindset Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-CA$6m

Dec 31 2022n/an/a

-CA$5m

Sep 30 2022n/an/a

-CA$9m

Jun 30 2022CA$784kCA$225k

-CA$17m

Mar 31 2022n/an/a

-CA$21m

Dec 31 2021n/an/a

-CA$21m

Sep 30 2021n/an/a

-CA$16m

Jun 30 2021CA$477kCA$179k

-CA$12m

Mar 31 2021n/an/a

-CA$7m

Jun 30 2020CA$85kCA$33k

-CA$643k

Compensation vs Market: James's total compensation ($USD565.03K) is about average for companies of similar size in the US market ($USD740.57K).

Compensation vs Earnings: James's compensation has increased whilst the company is unprofitable.

CEO

James Lanthier (48 yo)

no data

Tenure

CA$783,754

Compensation

Mr. James Andre-Charles Lanthier serves as Chief Executive Officer of Mindset Pharma Inc. He served as Chief Executive Officer, President and Director of Magnolia Colombia Ltd. since October 1, 2018 until...

Board Members

NamePositionTenureCompensationOwnership
Joseph Araujo
Chief Scientific Officer3.1yrsCA$833.75k0.089%
$ 48.0k
Abdelmalik Slassi
Senior VP of Innovation & Member of Scientific Advisory Boardno dataCA$918.75k1.5%
$ 812.8k
James Passin
Independent Director3.1yrsCA$213.50k3.01%
$ 1.6m
Richard Patricio
Independent Chairman3.1yrsCA$917.51k3.8%
$ 2.1m
Philip Williams
Independent Director3.1yrsCA$213.50k2.7%
$ 1.5m
Joseph Gabriele
Member of Scientific Advisory Board2.6yrsno datano data
Michael Rogawski
Member of Scientific Advisory Boardno datano datano data
Ishrat Husain
Member of Scientific Advisory Board2.3yrsno datano data
Ian Dean
Former Director of Preclinical & Member of Scientific Advisory Boardno datano datano data
Ali Kandil
Member of Scientific Advisory Boardno datano datano data

3.1yrs

Average Tenure

49yo

Average Age

Experienced Board: MSST.F's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/28 17:35
End of Day Share Price 2023/10/24 00:00
Earnings2023/03/31
Annual Earnings2022/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mindset Pharma Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stefan QuennevilleEchelon Wealth Partners Inc.
Patrick TrucchioH.C. Wainwright & Co.